首页> 外文期刊>Experimental and clinical transplantation >Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease
【24h】

Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease

机译:免疫移植介导的原发性肾脏疾病的肾脏移植受者的长期不良结果

获取原文
           

摘要

Objectives: Recurrent glomerulonephritis can nega-tively affect kidney allograft survival. However, how primary renal disease affects transplant outcomes in the new era of immunosuppression remains unclear. Materials and Methods: We categorized 426 kidney transplant recipients (performed from 1996 to 2007) into 4 disease groups: (1) 99 recipients with biopsy-proven immunologically mediated kidney disease, (2) 40 recipients with urologic disease, (3) 67 recipients with polycystic kidney disease, and (4) 220 recipients with other causes of terminal renal failure/uncertain kidney disease. Long-term transplant outcomes were compared between groups at 1, 5, and 10 years of follow-up. Results: Compared with the urologic, polycystic, and other diseases groups, the immunologic group showed significantly lower time of graft survival (9.5 ± 4 vs 8 ± 4 vs 8.5 ± 4 vs 7 ± 4 years, respectively) and estimated glomerular filtration rate (52.5 ± 32 vs 49 ± 22 vs 50 ± 32 vs 35.5 ± 30 mL/min; P .05). Relative risk of 10-year graft loss for the immunologic group was 2.8 (95% confidence interval, 1.6-4.9). Recurrence rate was 12% in the immunologic group versus 1% and 0% in the other diseases and remaining groups ( P .05). The relative risk of 10-year graft loss for patients with recurrence was 2.7 (95% confidence interval, 1.2-6.3). Ten-year graft loss rates for patients with biopsy-proven acute rejection, chronic allograft nephropathy, and recurrent glomerulonephritis were 30%, 23%, and 42% ( P .05). For those with biopsy-proven recurrent glomerulonephritis, 10-year estimated glomerular filtration rate was significantly lower than for those with biopsy-proven acute rejection or chronic allograft nephropathy (14 ± 6 vs 18 ± 7 vs 30 ± 10 mL/min; P .05). Conclusions: Kidney transplant recipients with immunologically mediated kidney diseases have inferior long-term allograft survival and function versus patients with other causes of renal failure. Recurrence represents the strongest risk factor for premature loss of function and transplant failure.
机译:目的:复发性肾小球肾炎可对肾脏同种异体移植的存活产生负面影响。然而,在新的免疫抑制时代,原发性肾脏疾病如何影响移植结果仍不清楚。材料和方法:我们将426名肾脏移植受者(1996年至2007年进行)分为4个疾病组:(1)99名经活检证实为免疫学介导的肾脏疾病的接受者,(2)40名泌尿科疾病的接受者,(3)67名接受者多囊肾疾病,以及(4)220名患有其他原因导致终末性肾衰竭/不确定性肾脏疾病的接受者。在1、5和10年的随访中比较了各组的长期移植结果。结果:与泌尿科,多囊性和其他疾病组相比,免疫组的移植物存活时间显着降低(分别为9.5±4 vs 8±4 vs 8.5±4 vs 7±4年)和估计的肾小球滤过率( 52.5±32 vs 49±22 vs 50±32 vs 35.5±30 mL / min; P <0.05)。免疫组10年移植物丢失的相对风险为2.8(95%置信区间1.6-4.9)。免疫组的复发率为12%,而其他疾病和其余组的复发率为1%和0%(P <.05)。复发患者10年移植物丢失的相对风险为2.7(95%置信区间1.2-6.3)。经活检证实为急性排斥反应,慢性同种异体肾病和复发性肾小球肾炎的患者十年移植物丢失率分别为30%,23%和42%(P <.05)。对于经活检证实为复发性肾小球肾炎的患者,10年估计肾小球滤过率显着低于经活检证实为急性排斥反应或慢性同种异体肾病的患者(14±6 vs 18±7 vs 30±10 mL / min; P < .05)。结论:与其他原因导致肾衰竭的患者相比,具有免疫学介导的肾脏疾病的肾脏移植受者的长期同种异体移植存活和功能较差。复发是功能过早丧失和移植失败的最强危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号